Home Compare CI vs HUM
Stock Comparison · Industry comparison · Healthcare Plans

The Cigna vs Humana: Which Stock Looks Stronger in 2026?

The Cigna holds the cleaner structural position, with stability as the main driver and profitability adding further support. Humana still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across stability and profitability, rather than sitting in one isolated gap. The overall score gap is 11 points in favour of The Cigna Group.

INDUSTRY COMPARISON

Both operate in: Healthcare Plans

This comparison is based on industry proximity, not on functional trajectory similarity. CI and HUM share the same industry classification.

For a similarity-based comparison, see how The Cigna and Humana each position within their functional peer groups in AssetNext.

Peer-Relative Score
CI
The Cigna Group
62
Peer-Score
Signal qualityMedium
vs
HUM
Humana Inc.
51
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: CI vs HUM Profitability 60 40 Stability 64 33 Valuation 82 80 Growth 30 40 CI HUM
Gap Ranking
#1 Stability +31
#2 Profitability +20
#3 Growth +10
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for CI and HUM Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer CIHUM Relative valuation Structural strength

The Cigna Group looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
The Cigna Group sits in the stronger part of the group on stability, while Humana Inc. is closer to mid-pack.
Profitability
Both look solid on profitability, though The Cigna Group still holds the stronger peer position.
Stability — Dominant Gap
CI
64
HUM
33
Gap+31in favour of CI

The stability gap is wide, with the stronger side looking materially steadier through time.

What else supports the lead

Return on equity adds support too, with a 8.1-point advantage.

What this means for the comparison

Stability is the clearest driver of the lead, with profitability adding further support — though growth still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the CI vs HUM comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-and-profitability comparisons

Explore how CI and HUM each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.